These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 33053028)
1. Does vancomycin administered at an empirical dose ensure coverage of pediatric patients against gram-positive pathogens? Pires FR; Paula SI; Delgado AF; Carvalho WB; Duarte NJC; Morales Júnior R; Santos SRCJ Rev Bras Ter Intensiva; 2020; 32(3):391-397. PubMed ID: 33053028 [TBL] [Abstract][Full Text] [Related]
2. The relationship between vancomycin AUC/MIC and trough concentration, age, dose, renal function in Chinese critically ill pediatric patients. Chen J; Huang X; Bu S; Chen X; Zhou J; Liu X; Guo X; Li L; Zhang J Pharmacol Res Perspect; 2021 Dec; 9(6):e00885. PubMed ID: 34664790 [TBL] [Abstract][Full Text] [Related]
3. Vancomycin pharmacokinetic-pharmacodynamic parameters to optimize dosage administration in critically ill children. Giachetto GA; Telechea HM; Speranza N; Oyarzun M; Nanni L; Menchaca A Pediatr Crit Care Med; 2011 Nov; 12(6):e250-4. PubMed ID: 21057350 [TBL] [Abstract][Full Text] [Related]
4. Population Pharmacokinetics and Pharmacodynamic Target Attainment of Vancomycin in Neonates on Extracorporeal Life Support. Cies JJ; Moore WS; Nichols K; Knoderer CA; Carella DM; Chopra A Pediatr Crit Care Med; 2017 Oct; 18(10):977-985. PubMed ID: 28650363 [TBL] [Abstract][Full Text] [Related]
5. Population Pharmacokinetics and Dose Optimization of Vancomycin in Critically Ill Children. Sridharan K; Abbasi MY; Mulubwa M Eur J Drug Metab Pharmacokinet; 2021 Jul; 46(4):539-546. PubMed ID: 34156647 [TBL] [Abstract][Full Text] [Related]
6. An evaluation of vancomycin dosing for complicated infections in pediatric patients. Durham SH; Simmons ML; Mulherin DW; Foland JA Hosp Pediatr; 2015 May; 5(5):276-81. PubMed ID: 25934812 [TBL] [Abstract][Full Text] [Related]
7. Correlation of a Vancomycin Pharmacokinetic Model and Trough Serum Concentrations in Pediatric Patients. Ploessl C; White C; Manasco K Pediatr Infect Dis J; 2015 Oct; 34(10):e244-7. PubMed ID: 26121203 [TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial. Zhang Z; Chen M; Yu Y; Pan S; Liu Y Antimicrob Resist Infect Control; 2018; 7():152. PubMed ID: 30564308 [TBL] [Abstract][Full Text] [Related]
9. Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections. James JK; Palmer SM; Levine DP; Rybak MJ Antimicrob Agents Chemother; 1996 Mar; 40(3):696-700. PubMed ID: 8851595 [TBL] [Abstract][Full Text] [Related]
10. Vancomycin dosage optimization in patients with malignant haematological disease by pharmacokinetic/pharmacodynamic analysis. Fernández de Gatta Mdel M; Santos Buelga D; Sánchez Navarro A; Dominguez-Gil A; García MJ Clin Pharmacokinet; 2009; 48(4):273-80. PubMed ID: 19492872 [TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetic analysis of vancomycin in pediatric continuous renal replacement therapy. Moffett BS; Morris J; Munoz F; Arikan AA Eur J Clin Pharmacol; 2019 Aug; 75(8):1089-1097. PubMed ID: 30937470 [TBL] [Abstract][Full Text] [Related]
13. Empirical Vancomycin Dosing in Pediatric Patients with Congenital Heart Disease and the Impact of Cardiopulmonary Bypass on Trough Concentrations. Thomas CA; Picone A; Menon S; Willis BC Pharmacotherapy; 2017 Nov; 37(11):1341-1346. PubMed ID: 28833385 [TBL] [Abstract][Full Text] [Related]
14. Vancomycin pharmacokinetics and predicted dosage requirements in pediatric cancer patients. Abdel Hadi O; Al Omar S; Nazer LH; Mubarak S; Le J J Oncol Pharm Pract; 2016 Jun; 22(3):448-53. PubMed ID: 26079639 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of Vancomycin Use in Late-Onset Neonatal Sepsis Using the Area Under the Concentration-Time Curve to the Minimum Inhibitory Concentration ≥400 Target. Bhongsatiern J; Stockmann C; Roberts JK; Yu T; Korgenski KE; Spigarelli MG; Desai PB; Sherwin CM Ther Drug Monit; 2015 Dec; 37(6):756-65. PubMed ID: 26562817 [TBL] [Abstract][Full Text] [Related]
16. Study of intragastric administration of doxycycline: pharmacokinetics including body fluid, endometrial and minimum inhibitory concentrations. Bryant JE; Brown MP; Gronwall RR; Merritt KA Equine Vet J; 2000 May; 32(3):233-8. PubMed ID: 10836479 [TBL] [Abstract][Full Text] [Related]
18. Improved vancomycin dosing in children using area under the curve exposure. Le J; Bradley JS; Murray W; Romanowski GL; Tran TT; Nguyen N; Cho S; Natale S; Bui I; Tran TM; Capparelli EV Pediatr Infect Dis J; 2013 Apr; 32(4):e155-63. PubMed ID: 23340565 [TBL] [Abstract][Full Text] [Related]
19. Spectrum of gram-positive bacteraemia and in vitro activities of daptomycin, linezolid and vancomycin against organisms isolated from cancer patients. Rolston KV; Kapadia M; Tarrand J; Coyle E; Prince RA Int J Antimicrob Agents; 2013 Jun; 41(6):516-20. PubMed ID: 23481658 [TBL] [Abstract][Full Text] [Related]
20. Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate. Frymoyer A; Hersh AL; Benet LZ; Guglielmo BJ Pediatr Infect Dis J; 2009 May; 28(5):398-402. PubMed ID: 19295465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]